Clear cell carcinoma of the ovary: evaluation of prognostic parameters based on a clinicopathological analysis of 100 cases

被引:29
作者
Bennett, Jennifer A.
Dong, Fei
Young, Robert H.
Oliva, Esther
机构
[1] Massachusetts Gen Hosp, James Homer Wright Pathol Labs, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
morphological patterns; ovarian clear cell carcinoma; prognosis; tumour grading; UNIVERSAL GRADING SYSTEM; ADENOFIBROMATOUS COMPONENTS; EPITHELIAL CARCINOMA; SEROUS CARCINOMA; FOLLOW-UP; ADENOCARCINOMA; ENDOMETRIOSIS; CANCER; SURVIVAL; TUMORS;
D O I
10.1111/his.12514
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims The aim of this study was to evaluate the clinicopathological features of ovarian clear cell carcinomas in order to identify which, if any, are prognostically significant, and to determine whether there is value in grading these tumours. Methods and results One hundred tumours with clinical follow-up were reviewed. Features evaluated included age, preoperative/intraoperative rupture, size, architectural pattern(s), presence of oxyphilic cells, degree of cytological atypia, nucleolar grade, mitoses, background precursor and stage. Survival differences were analysed using the log-rank test and Kaplan-Meier estimator. Stage and lymph node status were the only parameters that were statistically significant (P<0.0001). Patients with stage I disease (71%) had a 92% 5-year survival compared to a 31% 5-year survival in advanced stage disease (29%). Those with negative lymph nodes (92%) had an 80% 5-year survival compared to a 22% 5-year survival for those with positive nodes (8%). Conclusions This study shows that stage and lymph node status are the only prognostically significant parameters in patients with ovarian clear cell carcinoma. It also confirms that most patients with clear cell carcinoma present with disease confined to the ovary, and have an excellent prognosis. Grading ovarian clear cell carcinomas based on morphological features is not recommended, as none are of prognostic significance.
引用
收藏
页码:808 / 815
页数:8
相关论文
共 47 条
[1]   MESONEPHROID TUMOURS OF OVARY [J].
ANDERSON, MC ;
LANGLEY, FA .
JOURNAL OF CLINICAL PATHOLOGY, 1970, 23 (03) :210-&
[2]   Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010 [J].
Anglesio, Michael S. ;
Carey, Mark S. ;
Koebel, Martin ;
MacKay, Helen ;
Huntsman, David G. .
GYNECOLOGIC ONCOLOGY, 2011, 121 (02) :407-415
[3]  
[Anonymous], 1971, Acta Obstet Gynecol Scand, V50, P1
[4]  
AURE JC, 1971, OBSTET GYNECOL, V37, P860
[5]  
Benda JA., 1994, GOG pathology manual
[6]   Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers [J].
Chan, John K. ;
Teoh, Deanna ;
Hu, Jessica M. ;
Shin, Jacob Y. ;
Osann, Kathryn ;
Kapp, Daniel S. .
GYNECOLOGIC ONCOLOGY, 2008, 109 (03) :370-376
[7]   CLEAR CELL-CARCINOMA OF THE OVARY - A STUDY OF 59 CASES [J].
CROZIER, MA ;
COPELAND, LJ ;
SILVA, EG ;
GERSHENSON, DM ;
STRINGER, CA .
GYNECOLOGIC ONCOLOGY, 1989, 35 (02) :199-203
[8]   Endometriosis Does Not Confer Improved Prognosis in Ovarian Carcinoma of Uniform Cell Type [J].
Cuff, Justin ;
Longacre, Teri A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (05) :688-695
[9]   Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary [J].
Davis, Michelle ;
Rauh-Hain, J. Alejandro ;
Andrade, Carolina ;
Boruta, David M., II ;
Schorge, John O. ;
Horowitz, Neil S. ;
May, Taymaa ;
del Carmen, Marcela G. .
GYNECOLOGIC ONCOLOGY, 2014, 132 (03) :760-766
[10]  
DOSHI N, 1977, CANCER-AM CANCER SOC, V39, P2658, DOI 10.1002/1097-0142(197706)39:6<2658::AID-CNCR2820390653>3.0.CO